The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome

Cancer Letters

Volumn 228, Issue 1-2, 2005, Pages 241-246

  Pajic, Marina ^a   Norris, Murray D ^a   Cohn, S L ^b   Haber, Michelle ^a  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ABCC1; Cytotoxic; Drug resistance; MRP1; MYCN; Neuroblastoma

Indexed keywords

BENZBROMARONE; BENZOTHIOPHENE DERIVATIVE; CYTOTOXIC AGENT; DIFLOXACIN; DIHYDROPYRIDINE DERIVATIVE; LY 329146; MULTIDRUG RESISTANCE PROTEIN 1; NIK 250; PROBENECID; RETINOIC ACID; SULFINPYRAZONE; UNCLASSIFIED DRUG; VERLUKAST;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER GENETICS; CANCER RESISTANCE; FUNCTIONAL PROTEOMICS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; LUNG SMALL CELL CANCER; METASTASIS; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; NEUROBLASTOMA; NONHUMAN; ONCOGENE; PHARMACOGENETICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN TARGETING; SHORT SURVEY; T CELL LEUKEMIA;

EID: 23944438374     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.060     Document Type: Review

References (37)

1. G.M. Brodeur Neuroblastoma: biological insights into a clinical enigma Nat. Rev. Cancer 3 2003 203 216
2. K.W. Scotto Transcriptional regulation of ABC drug transporters Oncogene 22 2003 7496 7511
3. S.P. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, and K.C. Almquist Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1992 1650 1654
4. D.R. Hipfner, R.G. Deeley, and S.P. Cole Structural, mechanistic and clinical aspects of MRP1 Biochim. Biophys. Acta 1461 1999 359 376
5. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J. Natl. Cancer Inst. 92 2000 1295 1302
6. J. Wijnholds, R. Evers, M.R. van Leusden, C.A. Mol, G.J. Zaman, and U. Mayer Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein Nat. Med. 3 1997 1275 1279
7. M.D. Norris, S.B. Bordow, G.M. Marshall, P.S. Haber, S.L. Cohn, and M. Haber Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma N. Engl. J. Med. 334 1996 231 238
8. G.F. Sullivan, J.M. Yang, A. Vassil, J. Yang, J. Bash-Babula, and W.N. Hait Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells J. Clin. Invest. 105 2000 1261 1267
9. Y. Fukushima, Y. Oshika, T. Tokunaga, H. Hatanaka, M. Tomisawa, and K. Kawai Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer Eur. J. Cancer 35 1999 935 938
10. C.F. Manohar, J.A. Bray, H.R. Salwen, J. Madafiglio, A. Cheng, and C. Flemming MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma Oncogene 23 2004 753 762
11. R.C. Seeger, G.M. Brodeur, H. Sather, A. Dalton, S.E. Siegel, and K.Y. Wong Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas N. Engl. J. Med. 313 1985 1111 1116
12. M. Schwab, H.E. Varmus, and J.M. Bishop Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture Nature 316 1985 160 162
13. C.J. Thiele, C.P. Reynolds, and M.A. Israel Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma Nature 313 1985 404 406
14. N. Ikegaki, J. Bukovsky, and R.H. Kennett Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities Proc. Natl. Acad. Sci. USA 83 1986 5929 5933
15. E.M. Blackwood, and R.N. Eisenman Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc Science 251 1991 1211 1217
16. E.M. Blackwood, B. Luscher, L. Kretzner, and R.N. Eisenman The Myc:Max protein complex and cell growth regulation Cold Spring Harb. Symp. Quant. Biol. 56 1991 109 117
17. S.B. Bordow, M. Haber, J. Madafiglio, B. Cheung, G.M. Marshall, and M.D. Norris Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma Cancer Res. 54 1994 5036 5040
18. M.D. Norris, S.B. Bordow, P.S. Haber, G.M. Marshall, M. Kavallaris, and J. Madafiglio Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma Eur. J. Cancer 33 1997 1911 1916
19. T. Matsunaga, H. Shirasawa, T. Hishiki, H. Enomoto, K. Kouchi, and Y. Ohtsuka Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior Jpn. J. Cancer Res. 89 1998 1276 1283
20. P. Bader, F. Schilling, M. Schlaud, R. Girgert, R. Handgretinger, and T. Klingebiel Expression analysis of multidrug resistance associated genes in neuroblastomas Oncol. Rep. 6 1999 1143 1146
21. M. Haber, S.B. Bordow, P.S. Haber, G.M. Marshall, B.W. Stewart, and M.D. Norris The prognostic value of MDR1 gene expression in primary untreated neuroblastoma Eur. J. Cancer 33 1997 2031 2036
22. J. Bourhis, J. Benard, O. Hartmann, L. Boccon-Gibod, J. Lemerle, and G. Riou Correlation of MDR1 gene expression with chemotherapy in neuroblastoma J. Natl. Cancer Inst. 81 1989 1401 1405
23. A. Nakagawara, K. Kadomatsu, S. Sato, K. Kohno, H. Takano, and K. Akazawa Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas Cancer Res. 50 1990 3043 3047
24. M. Favrot, V. Combaret, E. Goillot, J.P. Wagner, E. Bouffet, and F. Mazingue Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies Br. J. Cancer. 64 1991 233 238
25. H.S. Chan, G. Haddad, P.S. Thorner, G. DeBoer, Y.P. Lin, and N. Ondrusek P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma N. Engl. J. Med. 325 1991 1608 1614
26. H. Goto, N. Keshelava, K.K. Matthay, J.N. Lukens, R.B. Gerbing, and D.O. Stram Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors Med. Pediatr. Oncol. 35 2000 619 622
27. Q.J. Lu, F. Dong, J.H. Zhang, X.H. Li, Y. Ma, and W.G. Jiang Expression of multidrug resistance-related markers in primary neuroblastoma Chin. Med. J. Engl. 117 2004 1358 1363
28. J.D. Allen, R.F. Brinkhuis, L. van Deemter, J. Wijnholds, and A.H. Schinkel Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance Cancer Res. 60 2000 5761 5766
29. M. Haber, S.B. Bordow, J. Gilbert, J. Madafiglio, M. Kavallaris, and G.M. Marshall Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells Oncogene 18 1999 2777 2782
30. A.E. Peaston, M. Gardaneh, A.V. Franco, J.E. Hocker, K.M. Murphy, and M.L. Farnsworth MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells Br. J. Cancer 85 2001 1564 1571
31. W.A. Weiss, K. Aldape, G. Mohapatra, B.G. Feuerstein, and J.M. Bishop Targeted expression of MYCN causes neuroblastoma in transgenic mice Eur. Mol. Biol. Org. J. 16 1997 2985 2995
32. C.S. Hackett, J.G. Hodgson, M.E. Law, J. Fridlyand, K. Osoegawa, and P.J. de Jong Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors Cancer Res. 63 2003 5266 5273
33. M. Lastowska, Y.J. Chung, N. Cheng Ching, M. Haber, M.D. Norris, and U.R. Kees Regions syntenic to human 17q are gained in mouse and rat neuroblastoma Genes Chromosomes Cancer 40 2004 158 163
34. L.M. Hansford, W.D. Thomas, J.M. Keating, C.A. Burkhart, A.E. Peaston, and M.D. Norris Mechanisms of embryonal tumor initiation: distinct roles for MYCN expression and MYCN amplification Proc. Natl. Acad. Sci. USA. 101 2004 12664 12669
35. C.A. Burkhart, A.J. Cheng, J. Madafiglio, M. Kavallaris, M. Mili, and G.M. Marshall Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma J. Natl. Cancer Inst. 95 2003 1394 1403
36. A. Lorico, G. Rappa, R.A. Finch, D. Yang, R.A. Flavell, and A.C. Sartorelli Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione Cancer Res. 57 1997 5238 5242
37. B.J. Kuss, M. Corbo, W.M. Lau, D.A. Fennell, N.M. Dean, and F.E. Cotter In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapy Int. J. Cancer 98 2002 128 133